Business Context and Reporting Period
Company: Gladstone Commercial Corporation (GOOD)
Filing Type: Form 8-K (Current Report)
Reporting Date: September 27, 2019 (Event Date: September 25, 2019)
The Company entered into a material definitive agreement to issue new preferred stock and filed Articles Supplementary to reclassify authorized common stock. The transaction is expected to close on or about October 4, 2019.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than operational financial results. Key metrics include:
- Offering Size: 2,400,000 shares of newly created 6.625% Series E Cumulative Redeemable Preferred Stock.
- Liquidation Preference: $25.00 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 360,000 shares.
- Use of Proceeds: Net proceeds will be used to redeem all outstanding shares of the 7.75% Series A and 7.50% Series B Cumulative Redeemable Preferred Stock.
- Capital Structure Impact: Authorized Common Stock decreased from 87,700,000 to 83,700,000 shares to accommodate 4,000,000 shares of Series E Preferred Stock.
Note: The filing text does not provide specific values for revenue, profit, cash flow, margins, or total debt levels.
Material Changes Versus Prior Period
The primary material change is the restructuring of the Company's preferred stock portfolio:
- Debt/Capital Refinancing: The Company is replacing higher-cost preferred stock (Series A at 7.75% and Series B at 7.50%) with lower-cost Series E stock (6.625%).
- Authorized Shares: Reclassification of 4,000,000 shares from Common Stock to Series E Preferred Stock.
- Operating Partnership: Adoption of Exhibit SEP to issue Series E Preferred Units in the Operating Partnership equivalent to the Company's stock issuance.
Guidance, Outlook, and Risks
Management Commentary: Management intends to use the offering to reduce interest expense by redeeming higher-coupon preferred securities. The transaction is contingent upon the closing of the underwriting agreement.
Risks and Contingencies:
- The transaction is subject to closing conditions outlined in the Underwriting Agreement.
- The summary of terms is qualified by the full Underwriting Agreement filed as Exhibit 1.1.
Important Facts for Investor Verification
- Verify the final closing date and whether the underwriters exercised the 360,000 share over-allotment option.
- Confirm the exact redemption price and timing for the Series A and Series B preferred stock.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and conditions.
- Monitor the impact of the lower dividend rate (6.625% vs. 7.75%/7.50%) on future cash flow requirements.